This Conagra Brands Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Author: Avi Kapoor | February 24, 2025 01:21pm
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Wells Fargo analyst Derek Archila downgraded the rating for Exelixis, Inc. (NASDAQ:EXEL) from Overweight to Equal-Weight and maintained the price target of $36. Exelixis shares closed at $36.85 on Friday. See how other analysts view this stock.
B of A Securities analyst John Murphy downgraded Rivian Automotive, Inc. (NASDAQ:RIVN) from Neutral to Underperform and lowered the price target from $13 to $10. Rivian Automotive shares closed at $12.97 on Friday. See how other analysts view this stock.
Goldman Sachs analyst Leah Jordan downgraded Conagra Brands, Inc. (NYSE:CAG) from Buy to Neutral and lowered the price target from $33 to $26. Conagra Brands shares closed at $25.79 on Friday. See how other analysts view this stock.
Morgan Stanley analyst Stephen Grambling downgraded Boyd Gaming Corporation (NYSE:BYD) from Overweight to Equal-Weight and lowered the price target from $82 to $81. Boyd Gaming shares closed at $76.86 on Friday. See how other analysts view this stock.
Mizuho analyst Graig Suvannavejh downgraded the rating for Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) from Outperform to Neutral and slashed the price target from $140 to $132. Intra-Cellular Therapies shares closed at $128.60 on Friday. See how other analysts view this stock.
Considering buying CAG stock? Here’s what analysts think:
